Nöropsikiyatrik Sistemik Lupus Eritematozus ile İlişkili Süper Refrakter Status Epileptikus: Nadir Görülen Bir Olgu’ Makalesine İlişkin Editöre Mektup

Kaynakça (7)

1. Göl MF, Yetkin MF, Köse EG, Erdoğan FF. Nöropsikiyatrik Sistemik Lupus Eritematozus İle İlişkili Süper Refrakter Status Epileptikus: Nadir Görülen Bir Olgu. Epilepsi 2019;25(1):35–9
2. Holmqvist M, Simard JF, Asplund K, Arkema EV. Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies. RMD Open 2015;1(1):e000168
3. Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, et al. Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Care Res (Hoboken) 2018;70(10):1478–87
4. Vieira-Karuta SC, Silva IC, Liberalesso PB, Bandeira M, Janz L Jr, Löhr A Jr. Epileptic seizures and EEG features in juvenile systemic lupus erythematosus. Arq Neuropsiquiatr 2008;66(3A):468– 70
5. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46(4):1029–35
6. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia 2000;41(Suppl 2):S23–30
7. Guraieb-Chahín P, Cantú-Brito C, Soto-Mota A, Guerrero-Torres L, Flores-Silva F, Chiquete E, et al. Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome. Lupus 2020;29(5):437–45. 8. van Zaane B, Nur E, Squizzato A, Gerdes VE, Buller HR, Dekkers OM, et al. Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J Thromb Haemost 2010;8(11):2483–93.